Interleukin-28b: A Key Piece of the Hepatitis C Virus Recovery Puzzle

被引：25

作者：

Thio, Chloe L. ^{[1
]}

Thomas, David L. ^{[1
]}

机构：

[1] Johns Hopkins Sch Med, Baltimore, MD USA

来源：

GASTROENTEROLOGY | 2010年 / 138卷 / 04期

关键词：

GENETIC-VARIATION; INTERFERON-ALPHA; PEGINTERFERON ALPHA-2A; CLINICAL-OUTCOMES; PATHWAY GENES; INFECTION; RIBAVIRIN; POLYMORPHISMS; CLEARANCE; THERAPY;

D O I：

10.1053/j.gastro.2010.02.033

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1240 / 1243

页数：4

共 30 条

[1] Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance [J].

An, Ping ;

Thio, Chloe L. ;

Kirk, Gregory D. ;

Donfield, Sharyne ;

Goedert, James J. ;

Winkler, Cheryl A. .

JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (08) :1159-1165

[2] Prioritizing GWAS Results: A Review of Statistical Methods and Recommendations for Their Application [J].

Cantor, Rita M. ;

Lange, Kenneth ;

Sinsheimer, Janet S. .

AMERICAN JOURNAL OF HUMAN GENETICS, 2010, 86 (01) :6-22

[3] ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment [J].

Chen, Limin ;

Sun, Jing ;

Meng, Larry ;

Heathcote, Jenny ;

Edwards, Aled M. ;

McGilvray, Ian D. .

JOURNAL OF GENERAL VIROLOGY, 2010, 91 :382-388

[4] Interferon-λ Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family [J].

Gad, Hans Henrik ;

Dellgren, Christoffer ;

Hamming, Ole J. ;

Vends, Susanne ;

Paludan, Soren R. ;

Hartmann, Rune .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (31) :20869-20875

[5] Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance [J].

Ge, Dongliang ;

Fellay, Jacques ;

Thompson, Alexander J. ;

Simon, Jason S. ;

Shianna, Kevin V. ;

Urban, Thomas J. ;

Heinzen, Erin L. ;

Qiu, Ping ;

Bertelsen, Arthur H. ;

Muir, Andrew J. ;

Sulkowski, Mark ;

McHutchison, John G. ;

Goldstein, David B. .

NATURE, 2009, 461 (7262) :399-401

[6] The International HapMap Project [J].

Gibbs, RA ;

Belmont, JW ;

Hardenbol, P ;

Willis, TD ;

Yu, FL ;

Yang, HM ;

Ch'ang, LY ;

Huang, W ;

Liu, B ;

Shen, Y ;

Tam, PKH ;

Tsui, LC ;

Waye, MMY ;

Wong, JTF ;

Zeng, CQ ;

Zhang, QR ;

Chee, MS ;

Galver, LM ;

Kruglyak, S ;

Murray, SS ;

Oliphant, AR ;

Montpetit, A ;

Hudson, TJ ;

Chagnon, F ;

Ferretti, V ;

Leboeuf, M ;

Phillips, MS ;

Verner, A ;

Kwok, PY ;

Duan, SH ;

Lind, DL ;

Miller, RD ;

Rice, JP ;

Saccone, NL ;

Taillon-Miller, P ;

Xiao, M ;

Nakamura, Y ;

Sekine, A ;

Sorimachi, K ;

Tanaka, T ;

Tanaka, Y ;

Tsunoda, T ;

Yoshino, E ;

Bentley, DR ;

Deloukas, P ;

Hunt, S ;

Powell, D ;

Altshuler, D ;

Gabriel, SB ;

Qiu, RZ .

NATURE, 2003, 426 (6968) :789-796

[7] Common Genetic Variation and Human Traits [J].

Goldstein, David B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (17) :1696-1698

[8] Early Changes in Hepatitis C Virus (HCV) Levels in Response to Peginterferon and Ribavirin Treatment in Patients with Chronic HCV Genotype 1 Infection [J].

Hoofnagle, Jay H. ;

Wahed, Abdus S. ;

Brown, Robert S., Jr. ;

Howell, Charles D. ;

Belle, Steven H. .

JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (08) :1112-1120

[9] Peginterferon Alfa-2a (40 kd) and ribavirin for Black American patients with chronic HCV genotype 1 [J].

Jeffers, LJ ;

Cassidy, W ;

Howell, CD ;

Hu, S ;

Reddy, KR .

HEPATOLOGY, 2004, 39 (06) :1702-1708

[10] Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study [J].

Jessner, W ;

Gschwantler, M ;

Steindl-Munda, P ;

Hofer, H ;

Watkins-Riedel, T ;

Wrba, F ;

Mueller, C ;

Gangi, A ;

Ferenci, P .

LANCET, 2001, 358 (9289) :1241-1242

← 1 2 3 →